title: Do currently available blood glucose monitors meet regulatory standards? 1-day public meeting in Arlington, Virginia.
abstract: Blood glucose monitors (BGMs) are approved by regulatory agencies based on their performance during strict testing conducted by their manufacturers. However, after approval, there is uncertainty whether BGMs maintain the accuracy levels that were achieved in the initial data. The availability of inaccurate BGM systems pose a public health problem because their readings serve as a basis for treatment decisions that can be incorrect. Several articles have concluded that BGMs in the marketplace may not consistently provide accurate results in accordance with the regulatory standards that led to approval. To address this growing concern, Diabetes Technology Society organized and conducted a 1-day public meeting on May 21, 2013, in Arlington, VA, presided by its president, David Klonoff, M.D., FACP, Fellow AIMBE, to determine whether BGMs on the market meet regulatory standards. The meeting consisted of four sessions in which Food and Drug Administration diabetes experts as well as leading academic clinicians and clinical chemists participated: (1) How is BGM performance determined? (2) Do approved BGMs perform according to International Organization for Standardization standards? (3) How do approved BGMs perform when used by patients and health care professionals? (4) What could be the consequence of poor BGM performance?
authors.affiliation: Mills Peninsula Health Services, San Mateo, CA 94401, USA. dklonoff@diabetestechnology.org
authors.forename: David C
authors.initials: DC
authors.lastname: Klonoff
authors.forename: Juliet S
authors.initials: JS
authors.lastname: Reyes
mesh_terms: D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring / Q000295:instrumentation / Q000592:standards; D018795:Device Approval; D003920:Diabetes Mellitus / Q000097:blood*; D006801:Humans; D038622:Internationality; D011358:Product Surveillance, Postmarketing; D012015:Reference Standards; D014481:United States; D014486:United States Food and Drug Administration / Q000592:standards; D014768:Virginia
chemical_list: D001786:Blood Glucose
references.citation: J Diabetes Sci Technol. 2013 Nov 01;7(6):1530-7
references.pmid: 24351179
references.citation: Disaster Manag Response. 2007 Apr-Jun;5(2):56-61
references.pmid: 17517364
references.citation: Diabetes Technol Ther. 2012 Apr;14(4):330-7
references.pmid: 22176154
references.citation: J Diabetes Sci Technol. 2013 Jan 01;7(1):144-52
references.pmid: 23439170
references.citation: J Diabetes Sci Technol. 2010 May 01;4(3):562-70
references.pmid: 20513321
references.citation: Diabetes Technol Ther. 2010 Mar;12(3):221-31
references.pmid: 20151773
references.citation: Nephron Clin Pract. 2011;117(3):c184-97
references.pmid: 20805691
references.citation: Diabetes Technol Ther. 2013 Mar;15(3):253-9
references.pmid: 23413939
references.citation: J Diabetes Sci Technol. 2012 Sep 01;6(5):1076-86
references.pmid: 23063033
references.citation: Clin Chem. 2005 Sep;51(9):1632-6
references.pmid: 16120948
references.citation: Curr Med Res Opin. 2012 Apr;28(4):525-31
references.pmid: 22435798
references.citation: Disaster Med Public Health Prep. 2012 Oct;6(3):232-40
references.pmid: 23077265